Role of Flagellin in Crohn's Disease: Emblematic of the Progress and Enigmas in Understanding Inflammatory Bowel Disease

被引:21
|
作者
Vijay-Kumar, Matam [1 ]
Gewirtz, Andrew T. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA
关键词
bacterial flagellin; enteric microbiota; Crohn's disease; TOLL-LIKE RECEPTOR-5; BACTERIAL FLAGELLIN; ESCHERICHIA-COLI; IMMUNE-RESPONSE; TYPHIMURIUM; EXPRESSION; MACROPHAGES; ACTIVATION; ANTIBODIES; ANTIGENS;
D O I
10.1002/ibd.20734
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Elevated immune responses to the enteric microbiota have long been associated with inflammatory bowel disease (IBD), especially Crohn's disease. In recent years there has been considerable progress in identifying a number of the specific bacterial and host molecules whose interactions mediate these responses. However, deciphering the role of these interactions in the pathophysiology of IBD remains a difficult challenge, in part due to the very complex nature of the epithelial cell / micorbial / immune cell interactions that play a central role in maintaining the gut's well-being. This article reviews such progress and discusses these challenges in the context of focusing on 1 particular protein, bacterial flagellin.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 50 条
  • [31] Effect of Obesity on Inflammatory Bowel Disease (Ulcerative Colitis vs Crohn's Disease)
    Dasu, Neethi
    Khalid, Yaser
    Blair, Brian
    Walters, Richard
    Chhoun, Christopher
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S678 - S679
  • [32] Experimental Inflammatory Bowel Disease: Lessons for the Treatment of Crohn's Disease and Ulcerative Colitis
    Ivan Fuss
    Pediatric Research, 1999, 45 : 746 - 746
  • [33] Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease
    Akolkar, PN
    GulwaniAkolkar, B
    Heresbach, D
    Lin, XY
    Fisher, S
    Katz, S
    Silver, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (12): : 2241 - 2244
  • [34] Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients
    Csongei, Veronika
    Jaromi, Luca
    Safrany, Eniko
    Sipeky, Csilla
    Magyari, Lili
    Farago, Bernadett
    Bene, Judit
    Polgar, Noemi
    Lakner, Lilla
    Sarlos, Patricia
    Varga, Marta
    Melegh, Bela
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (02) : 176 - 183
  • [35] Oro-facial granulomatosis: Crohn's disease or a new inflammatory bowel disease?
    Sanderson, J
    Nunes, C
    Escudier, M
    Barnard, K
    Shirlaw, P
    Odell, E
    Chinyama, C
    Challacombe, S
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (09) : 840 - 846
  • [36] Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn’s disease patients
    Veronika Csngei
    Luca Járomi
    EnikSáfrány
    Csilla Sipeky
    Lili Magyari
    Bernadett Faragó
    Judit Bene
    Noémi Polgár
    Lilla Lakner
    Patrícia Sarlós
    Márta Varga
    Béla Melegh
    World Journal of Gastroenterology, 2010, 16 (02) : 176 - 183
  • [37] Treatment of a chronic inflammatory bowel disease (Crohn's disease) with an oral glucocorticoid (budesonide)
    Hiddemann, W
    INTERNIST, 1996, 37 (02): : 195 - 196
  • [38] Vedolizumab for the Treatment of Crohn's Disease: Experience in an Inflammatory Bowel Disease Clinical Practice
    Blum, Andrew
    Nizialek, Gregory
    Parikh, Keyur
    Dave, Maneesh
    Katz, Jeffry
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S276 - S276
  • [39] Does inflammatory bowel disease (Unclassified) evolve into Crohn's disease or ulcerative colitis?
    Paul, S. P.
    Spray, C.
    Basude, D.
    Sandmann, S.
    Ramani, R.
    Sandhu, B. K.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S407 - S407
  • [40] Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis
    Parian, Alyssa
    Limketkai, Berkeley N.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (02) : 180 - 188